Literature DB >> 27622338

Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade.

Haidong Tang, Yang Wang, Lukasz K Chlewicki, Yuan Zhang, Jingya Guo, Wei Liang, Jieyi Wang, Xiaoxiao Wang, Yang-Xin Fu.   

Abstract

Entities:  

Year:  2016        PMID: 27622338     DOI: 10.1016/j.ccell.2016.08.011

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


× No keyword cloud information.
  36 in total

1.  T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma.

Authors:  Karolina Woroniecka; Pakawat Chongsathidkiet; Kristen Rhodin; Hanna Kemeny; Cosette Dechant; S Harrison Farber; Aladine A Elsamadicy; Xiuyu Cui; Shohei Koyama; Christina Jackson; Landon J Hansen; Tanner M Johanns; Luis Sanchez-Perez; Vidyalakshmi Chandramohan; Yen-Rei Andrea Yu; Darell D Bigner; Amber Giles; Patrick Healy; Glenn Dranoff; Kent J Weinhold; Gavin P Dunn; Peter E Fecci
Journal:  Clin Cancer Res       Date:  2018-02-07       Impact factor: 12.531

2.  Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy.

Authors:  Jingying Zhou; Man Liu; Hanyong Sun; Yu Feng; Liangliang Xu; Anthony W H Chan; Joanna H Tong; John Wong; Charing Ching Ning Chong; Paul B S Lai; Hector Kwong-Sang Wang; Shun-Wa Tsang; Tyler Goodwin; Rihe Liu; Leaf Huang; Zhiwei Chen; Joseph Jy Sung; King Lau Chow; Ka Fai To; Alfred Sze-Lok Cheng
Journal:  Gut       Date:  2017-09-22       Impact factor: 23.059

Review 3.  Synthetic immune niches for cancer immunotherapy.

Authors:  Jorieke Weiden; Jurjen Tel; Carl G Figdor
Journal:  Nat Rev Immunol       Date:  2017-08-30       Impact factor: 53.106

4.  STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.

Authors:  Ferdinandos Skoulidis; Michael E Goldberg; Danielle M Greenawalt; Matthew D Hellmann; Mark M Awad; Justin F Gainor; Alexa B Schrock; Ryan J Hartmaier; Sally E Trabucco; Laurie Gay; Siraj M Ali; Julia A Elvin; Gaurav Singal; Jeffrey S Ross; David Fabrizio; Peter M Szabo; Han Chang; Ariella Sasson; Sujaya Srinivasan; Stefan Kirov; Joseph Szustakowski; Patrik Vitazka; Robin Edwards; Jose A Bufill; Neelesh Sharma; Sai-Hong I Ou; Nir Peled; David R Spigel; Hira Rizvi; Elizabeth Jimenez Aguilar; Brett W Carter; Jeremy Erasmus; Darragh F Halpenny; Andrew J Plodkowski; Niamh M Long; Mizuki Nishino; Warren L Denning; Ana Galan-Cobo; Haifa Hamdi; Taghreed Hirz; Pan Tong; Jing Wang; Jaime Rodriguez-Canales; Pamela A Villalobos; Edwin R Parra; Neda Kalhor; Lynette M Sholl; Jennifer L Sauter; Achim A Jungbluth; Mari Mino-Kenudson; Roxana Azimi; Yasir Y Elamin; Jianjun Zhang; Giulia C Leonardi; Fei Jiang; Kwok-Kin Wong; J Jack Lee; Vassiliki A Papadimitrakopoulou; Ignacio I Wistuba; Vincent A Miller; Garrett M Frampton; Jedd D Wolchok; Alice T Shaw; Pasi A Jänne; Philip J Stephens; Charles M Rudin; William J Geese; Lee A Albacker; John V Heymach
Journal:  Cancer Discov       Date:  2018-05-17       Impact factor: 39.397

Review 5.  Programming CAR T cells to enhance anti-tumor efficacy through remodeling of the immune system.

Authors:  Xiaohui Wang; Zhiqiang Wu; Wei Qiu; Ping Chen; Xiang Xu; Weidong Han
Journal:  Front Med       Date:  2020-08-13       Impact factor: 4.592

6.  DNA Sensing in Mismatch Repair-Deficient Tumor Cells Is Essential for Anti-tumor Immunity.

Authors:  Changzheng Lu; Junhong Guan; Steve Lu; Qihuang Jin; Benoit Rousseau; Tianshi Lu; Dennis Stephens; Hongyi Zhang; Jiankun Zhu; Mingming Yang; Zhenhua Ren; Yong Liang; Zhida Liu; Chuanhui Han; Longchao Liu; Xuezhi Cao; Anli Zhang; Jian Qiao; Kimberly Batten; Mingyi Chen; Diego H Castrillon; Tao Wang; Bo Li; Luis A Diaz; Guo-Min Li; Yang-Xin Fu
Journal:  Cancer Cell       Date:  2020-12-17       Impact factor: 38.585

7.  Novel Therapy for Glioblastoma Multiforme by Restoring LRRC4 in Tumor Cells: LRRC4 Inhibits Tumor-Infitrating Regulatory T Cells by Cytokine and Programmed Cell Death 1-Containing Exosomes.

Authors:  Peiyao Li; Jianbo Feng; Yang Liu; Qiang Liu; Li Fan; Qing Liu; Xiaoling She; Changhong Liu; Tao Liu; Chunhua Zhao; Wei Wang; Guiyuan Li; Minghua Wu
Journal:  Front Immunol       Date:  2017-12-11       Impact factor: 7.561

Review 8.  Regulation of PD-L1: Emerging Routes for Targeting Tumor Immune Evasion.

Authors:  Yiting Wang; Huanbin Wang; Han Yao; Chushu Li; Jing-Yuan Fang; Jie Xu
Journal:  Front Pharmacol       Date:  2018-05-22       Impact factor: 5.810

9.  YKT6, as a potential predictor of prognosis and immunotherapy response for oral squamous cell carcinoma, is related to cell invasion, metastasis, and CD8+ T cell infiltration.

Authors:  Zongcheng Yang; Guangxing Yan; Lixin Zheng; Wenchao Gu; Fen Liu; Wei Chen; Xiujie Cui; Yue Wang; Yaling Yang; Xiyan Chen; Yue Fu; Xin Xu
Journal:  Oncoimmunology       Date:  2021-06-23       Impact factor: 8.110

Review 10.  Radiation effects on antitumor immune responses: current perspectives and challenges.

Authors:  Thomas Walle; Rafael Martinez Monge; Adelheid Cerwenka; Daniel Ajona; Ignacio Melero; Fernando Lecanda
Journal:  Ther Adv Med Oncol       Date:  2018-01-18       Impact factor: 8.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.